Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Change in Account Payables (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Change in Account Payables for 9 consecutive years, with -$22.1 million as the latest value for Q4 2025.

  • Quarterly Change in Account Payables fell 657.89% to -$22.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.7 million through Dec 2025, down 720.36% year-over-year, with the annual reading at -$3.7 million for FY2025, 720.36% down from the prior year.
  • Change in Account Payables hit -$22.1 million in Q4 2025 for Inspire Medical Systems, down from $6.5 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $21.3 million in Q2 2025 to a low of -$22.1 million in Q4 2025.
  • Historically, Change in Account Payables has averaged $1.3 million across 5 years, with a median of $1.6 million in 2021.
  • Biggest five-year swings in Change in Account Payables: soared 702.34% in 2021 and later tumbled 657.89% in 2025.
  • Year by year, Change in Account Payables stood at $1.3 million in 2021, then soared by 346.39% to $5.8 million in 2022, then plummeted by 130.92% to -$1.8 million in 2023, then skyrocketed by 322.65% to $4.0 million in 2024, then crashed by 657.89% to -$22.1 million in 2025.
  • Business Quant data shows Change in Account Payables for INSP at -$22.1 million in Q4 2025, $6.5 million in Q3 2025, and $21.3 million in Q2 2025.